Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials

BACKGROUND: The prospect for targeted therapies in advanced hepatocellular carcinoma (HCC) has dramatically changed since several recent clinical trials have yielded promising results. The number of second-line therapies is increasing, though the consequent challenge is to consider differences betwe...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Therap Adv Gastroenterol
Главные авторы: Wang, Dongxu, Yang, Xu, Lin, Jianzhen, Bai, Yi, Long, Junyu, Yang, Xiaobo, Seery, Samuel, Zhao, Haitao
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2020
Предметы:
Diagnosis, Management, and Prognostic Assessment of Liver Cancer
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313339/
https://ncbi.nlm.nih.gov/pubmed/32636928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820932483
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы